Point-of-Care Testing in Acute Hemorrhagic and Thrombotic States

 

 Permissions and Reprints

Monitoring of the coagulant state in patients who present with acute hemorrhagic or thrombotic conditions can be done by conventional coagulation assays; however, there is increasing attractiveness to the use of point-of-care tests that may yield not only a more rapid result than clinical laboratory testing but may also provide a more complete picture of the condition of the hemostatic system. Most widely used areas of study and application of point-of-care test concern patients who present with massive blood loss (such as in trauma or during major surgery), patients with a hypercoagulable state (such as in sepsis or other systemic inflammatory states), and patients who may need monitoring of antithrombotic treatment for acute coronary syndromes and revascularization procedures.

• References

• 1 Whitten CW, Greilich PE. Thromboelastography: past, present, and future. Anesthesiology 2000; 92 (05) 1223-1225
  CrossrefPubMedGoogle Scholar
• 2 Levi M. Self-management of anticoagulation. Expert Rev Cardiovasc Ther 2008; 6 (07) 979-985
  CrossrefPubMedGoogle Scholar
• 3 Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34 (08) 709-733
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Stein P, Kaserer A, Spahn GRGH, Spahn DR. Point of care coagulation monitoring in trauma patients. Semin Thromb Hemost 2017; 43 (04) 367-374
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Wirtz MR, Baumann HM, Klinkspoor JH, Goslings JC, Juffermans NP. Viscoelastic testing in trauma. Semin Thromb Hemost 2017; 43 (04) 375-385
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Bolliger D, Tanaka KA. Point-of-care coagulation testing in cardiac surgery. Semin Thromb Hemost 2017; 43 (05) 386-396
  Article in Thieme ConnectPubMedGoogle Scholar
• 7 Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: developing a thrombelastography®-guided transfusion algorithm. Anaesth Intensive Care 2012; 40 (06) 1007-1015
  CrossrefPubMedGoogle Scholar
• 8 Karlsson O. Experience of point-of-care devices in obstetrical care. Semin Thromb Hemost 2017; 43 (04) 397-406
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Abeysundara L, Mallett SV, Clevenger B. Point-of-care testing in liver disease and liver surgery. Semin Thromb Hemost 2017; 43 (04) 407-415
  Article in Thieme ConnectPubMedGoogle Scholar
• 10 Beynon C, Wessels L, Unterberg AW. Point-of-care testing in neurosurgery. Semin Thromb Hemost 2017; 43 (04) 416-422
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Iapichino G, Bianchi P, Ranucci M, Baryshnikova E. Point-of-care coagulation tests monitoring of direct oral anticoagulants and their reversal therapy: state of the art. Semin Thromb Hemost 2017; 43 (04) 423-432
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Johansson PI, Stensballe J, Vindeløv N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis 2010; 21 (02) 168-174
  CrossrefPubMedGoogle Scholar
• 13 Park MS, Martini WZ, Dubick MA. , et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009; 67 (02) 266-275 , discussion 275–276
  CrossrefPubMedGoogle Scholar
• 14 Collins PW, Macchiavello LI, Lewis SJ. , et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006; 135 (02) 220-227
  CrossrefPubMedGoogle Scholar
• 15 Wiegele M, Kozek-Langenecker S, Schaden E. Point-of-care testing in burn patients. Semin Thromb Hemost 2017; 43 (04) 433-438
  Article in Thieme ConnectPubMedGoogle Scholar
• 16 Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324 (7329): 71-86
  CrossrefPubMedGoogle Scholar
• 17 Pakala R, Waksman R. Currently available methods for platelet function analysis: advantages and disadvantages. Cardiovasc Revasc Med 2011; 12 (05) 312-322
  CrossrefPubMedGoogle Scholar
• 18 Bergmeijer TO, Godschalk TC, Janssen PWA. , et al. How long does it take for clopidogrel and ticagrelor to inhibit platelets in patients undergoing primary PCI? A detailed pharmacodynamic analysis. Semin Thromb Hemost 2017; 43 (04) 439-446
  Article in Thieme ConnectPubMedGoogle Scholar